Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Targeting H3K4 methylation as a therapeutic strategy for Huntington's disease (ChIP-seq)

ABSTRACT: Transcriptional dysregulation is an early feature of Huntington's disease (HD). We observed gene-specific changes in H3K4me3 at transcriptionally repressed promoters in R6/2 mouse and human HD brain. Genome-wide analysis showed a novel chromatin signature for this mark. Reducing the levels of the H3K4 demethylase SMCX/Jarid1c in primary neurons reversed down-regulation of key neuronal genes caused by mutant Huntingtin (Htt) expression. Finally, reduction of SMCX/Jarid1c in primary neurons from BACHD mice or the single Jarid1 in a Drosophila HD model was protective. Therefore, targeting this epigenetic signature may be an effective strategy to ameliorate the consequences of HD. ChIP-seq for H3K4me3 in wild type and R6/2 cortex and striatum at 8 and 12 weeks.

ORGANISM(S): Mus musculus

SUBMITTER: Christopher Ng 

PROVIDER: E-GEOD-48960 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

Transcriptional dysregulation is an early feature of Huntington disease (HD). We observed gene-specific changes in histone H3 lysine 4 trimethylation (H3K4me3) at transcriptionally repressed promoters in R6/2 mouse and human HD brain. Genome-wide analysis showed a chromatin signature for this mark. Reducing the levels of the H3K4 demethylase SMCX/Jarid1c in primary neurons reversed down-regulation of key neuronal genes caused by mutant Huntingtin expression. Finally, reduction of SMCX/Jarid1c in  ...[more]

Similar Datasets

Transcriptomics Targeting H3K4 methylation as a therapeutic strategy for Huntington's disease (RNA-seq)
2013-07-18 | E-GEOD-48962 | biostudies-arrayexpress
Transcriptomics Targeting H3K4 methylation as a therapeutic strategy for Huntington's disease (RNA-seq)
2013-07-18 | GSE48962 | GEO
Genomics Targeting H3K4 methylation as a therapeutic strategy for Huntington's disease (ChIP-seq)
2013-07-18 | GSE48960 | GEO
Genomics The Kdm5c histone demethylase controls enhancer and promoter function.
2013-04-01 | E-GEOD-34975 | biostudies-arrayexpress
Other Astrocyte-neuron contributions to Huntington’s disease dissected with ZFPs
2022-12-15 | GSE189647 | GEO
Transcriptomics Gene expression profiling of FACS-purified striatal medium spiny neurons in Huntington's disease model mouse
2020-06-03 | GSE113928 | GEO
Genomics ChIP-Seq of H3K4 methylation in neurons isolated from E16.5 mouse embryonic cortices from WT and SMCX KO mice
2016-01-27 | E-GEOD-61023 | biostudies-arrayexpress
Transcriptomics DREAM silencing is part of a neuroprotective mechanism in Huntington's disease
2016-02-01 | GSE48104 | GEO
Genomics The Kdm5c histone demethylase controls enhancer and promoter function.
2013-04-01 | GSE34975 | GEO
Transcriptomics Identification of the transcriptional biomarkers set linked to pathological remodelling of the eye tissues in various HD mouse models.
2022-03-25 | GSE199335 | GEO